8-K 1 sports8kviv_92704.txt REPORT 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 27, 2004 ------------------ In Vivo Medical Diagnostics, Inc. ------------------------------------------------------ (Exact Name of Registrant as Specified in its Charter) Colorado -------------------------------------------- (State or Other Jurisdiction of Incorporation) 000-49972 84-1579760 ---------------------- ----------------------------------- (Commission File Number) (I.R.S. Employer Identification No.) The Green House - Beechwood Business Park North Inverness Scotland IV2 3BL ------------------------------------------- ----------- (Address of Principal Executive Offices) (Zip Code) (Registrant's telephone number, including area code) - 011 44-1463-667-347 ------------------- Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [] Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Section 8 - Other Events Sports Information and Publishing Company has changed its name to In Vivo Medical Diagnostics and will trade under a new Symbol: IVVO. Section 9 - Financial Statements and Exhibits Item 9.01 Financial Statements and Exhibits. (c) Exhibits 99 Company Issued Press Release on September 27, 2004 The Company issued a press release on September 27, 2004, a copy of which is attached hereto as Exhibit 99. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IN VIVO MEDICAL DIAGNOSTICS, INC. Dated: September 27, 2004 By: /s/ Brian Cameron ----------------------------- Brian Cameron, Authorized Signatory, President and Chief Executive Officer

---------------------------------------------------------------------------------------------- COLORADO 000-49972 84-1579760 ---------------------------------------------------------------------------------------------- (State of Incorporation) (Commission File Number) (IRS Employer Identification No.) ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- 1869 W. Littleton Boulevard, Littleton, CO 80120 (Address of principal executive offices) (zip code) ----------------------------------------------------------------------------------------------

----------- ------------------ ----------------------------------- ------------------------------------------------ TECHNOLOGY PRODUCT KEY APPLICATIONS ----------- ------------------ ----------------------------------- ------------------------------------------------ IN Blood analyte Prothrombin blood clotting Minimally-invasive, accurate and safe, DEVELOPMENT measurement measuring device characteristic measuring device. ------------------ ----------------------------------- ------------------------------------------------ Fetal heart rate Consumer and professional Reliable at-home and professional medical heart monitor medical fetal well being monitor rate monitor for unborn babies ------------------ ----------------------------------- ------------------------------------------------ Predictor of Labor predictor Accurate prediction of onset of labor from 6 labor onset weeks out. Consumer device for maternity planning. In hospital, professional care for mothers identified at-risk for pre-term delivery. ---------- -------------------- ----------------------------------- ------------------------------------------------ IN Blood analyte Blood glucose monitor Non-invasive, accurate and safe, glucose (and RESEARCH other) concentration measuring device. ------------------ ----------------------------------- ------------------------------------------------ Medical Digital scanning machine Non-invasive, safe, high quality alternative to imaging 2D X-ray scanning. ------------------ ----------------------------------- ------------------------------------------------ Osteoporosis Bone density monitor Non-invasive instant display of bone mineral detection and density for osteoporosis patients. monitoring device ------------------ ----------------------------------- ------------------------------------------------ Internal In-surgery detection system Safe and accurate 3D positioning of instruments Surgery and probes during surgery. ----------- ------------------ ----------------------------------- ------------------------------------------------

PRODUCT PRINCIPAL ADVANTAGES Prothrombin-time blood clotting Significantly lower cost than competing devices; measuring device smaller in size than competing devices; and only requires two microlitres of microlitres of, significantly less invasive than the 20 microlitres of blood required by the only comparable systems currently manufactured. Fetal heart rate monitor Small non-invasive external device with reliable detection and continuous signal display that can be used by non-trained persons. Labor predictor External non-invasive devise with high negative and positive predictive success and ease of use. Blood glucose monitor Small inexpensive, non-invasive device with rapid continuous bulk measurement. Digital scanning machine Small, portable in expensive continuous display with No ionizing radiation. Bone density monitor Inexpensive, accurate and no ionizing radiation. In-surgery detection system Alternative to low power X-rays, used with tomography.

NAME AGE POSITION John Fuller 43 President, Chief Executive Officer and Director Brian Cameron 45 Chief Operating Officer and Director Graham Cooper 54 Chairman of the Board of Directors Bernard Turner 47 Chief Financial Officer David M. Barnes 64 Director

Name and Address Amount and Nature Title of Class of Beneficial Owner of Beneficial Owner Percentage (5) ----------------------------------------------------------------------------------------------------------- Common Stock Abacus Trust Company Limited 19,328,381 (1) 22.4% Unit 2, Taurus Park Europa Boulevard Warrington WA5 7YT England Common Stock Westek Limited 19,328,381 (1) 22.4% Unit 2, Taurus Park Europa Boulevard Warrington WA5 7YT England Common Stock Rodney Philip Jackson 6,392,695 7.4% The Green House, Beechwood Business Park North, Inverness, Scotland IV2 3BL Common Stock John Fuller 6,639,880 (2) 7.7% Easter Shian, Glen Quaich Amulree, Perthshire PH8 0DB Scotland Common Stock Brian Cameron 6,590,505 (3) 7.6% Campbell Cairns, Craigellachie Aberlour, Banffshire Scotland Common Stock Rubin Family Irrevocable Stock Trust 4,922,319 (4) 5.7% 25 Highland Boulevard Dix Hills, New York 11730 Common Stock All Directors and 38,951,461 45.2% Executive Officers as a Group (5)

Filing Compare · IN VERITAS MEDICAL DIAGNOSTICS, INC.